{"id":"https://openalex.org/W96233298","doi":null,"title":"[PPAR receptors and insulin sensitivity: new agonists in development].","display_name":"[PPAR receptors and insulin sensitivity: new agonists in development].","publication_year":2005,"publication_date":"2005-04-01","ids":{"openalex":"https://openalex.org/W96233298","mag":"96233298","pmid":"https://pubmed.ncbi.nlm.nih.gov/15959400"},"language":"fr","primary_location":{"id":"pmid:15959400","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15959400","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales d'endocrinologie","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"J-P P\u00e9gorier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210141964","display_name":"Institut Cochin","ror":"https://ror.org/051sk4035","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210096427","https://openalex.org/I4210141964"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"J-P P\u00e9gorier","raw_affiliation_strings":["INSERM U567/CNRS UMR 8104, Institut Cochin, D\u00e9partement d'Endocrinologie, Universit\u00e9 Paris V, F-75674 Paris Cedex 14, France. pegorier@cochin.inserm.fr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U567/CNRS UMR 8104, Institut Cochin, D\u00e9partement d'Endocrinologie, Universit\u00e9 Paris V, F-75674 Paris Cedex 14, France. pegorier@cochin.inserm.fr","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210141964"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210141964"],"apc_list":null,"apc_paid":null,"fwci":0.3097,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.47164895,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"66","issue":"2 Pt 2","first_page":"1S10","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.8769999742507935},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.7990000247955322},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.8859999775886536},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9789999723434448},{"id":"https://openalex.org/keywords/pparalpha-agonists","display_name":"PPAR\u03b1 agonist","score":0.8450000286102295},{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9419999718666077},{"id":"https://openalex.org/keywords/ppargamma-antagonist","display_name":"PPAR\u03b3 antagonist","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rxr-agonists","display_name":"RXR agonists","score":0.9039999842643738},{"id":"https://openalex.org/keywords/rexinoids","display_name":"rexinoids","score":0.9359999895095825},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.6650000214576721},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.671999990940094},{"id":"https://openalex.org/keywords/fluid-retention","display_name":"fluid retention","score":0.7310000061988831},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.4180000126361847},{"id":"https://openalex.org/keywords/glucose-and-lipid-metabolism","display_name":"glycolipid metabolism","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6121219396591187},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5906549096107483},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.5815410017967224},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5522503852844238},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5513739585876465},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5341737866401672},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5116048455238342},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5053949356079102},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49458667635917664},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.4933742582798004},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4799649715423584},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.4719613790512085},{"id":"https://openalex.org/C7341990","wikidata":"https://www.wikidata.org/wiki/Q10331450","display_name":"PPAR agonist","level":4,"score":0.4657737910747528},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3885360360145569}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15959400","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15959400","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales d'endocrinologie","raw_type":"English Abstract"},{"id":"mag:96233298","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15959400","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2092152115","https://openalex.org/W1499022122","https://openalex.org/W2038544181","https://openalex.org/W2055409225","https://openalex.org/W90468220","https://openalex.org/W2792659208","https://openalex.org/W2037455506","https://openalex.org/W2044431460","https://openalex.org/W2023375634","https://openalex.org/W6967197666"],"abstract_inverted_index":{"Thiazolidinediones":[0],"(or":[1],"glitazones)":[2],"are":[3,85,148,164],"synthetic":[4],"PPARgamma":[5,25,102,134,136],"(Peroxisome":[6],"Proliferator-Activated":[7],"Receptors":[8],"gamma)":[9],"ligands":[10],"with":[11,92,109],"well":[12,167],"recognized":[13],"effects":[14],"on":[15,53,115,123],"glucose":[16],"and":[17,38,43,74,126,160],"lipid":[18,116],"metabolism.":[19],"The":[20],"clinical":[21,90],"use":[22],"of":[23,69,101,120],"these":[24],"agonists":[26,112,146],"in":[27,46,87,107,150,156,174],"type":[28,175],"2":[29,176],"diabetic":[30,177],"patients":[31],"leads":[32],"to":[33,49,79,95],"an":[34,39],"improved":[35],"glycemic":[36],"control":[37],"inhanced":[40],"insulin":[41],"sensitivity,":[42],"at":[44],"least":[45],"animal":[47,161],"models,":[48],"a":[50],"protective":[51],"effect":[52],"pancreatic":[54],"beta-cell":[55],"function.":[56],"However,":[57],"they":[58],"can":[59],"produce":[60],"adverse":[61],"effects,":[62],"generally":[63],"mild":[64],"or":[65,89,106],"moderate,":[66],"but":[67,118],"some":[68],"them":[70],"(mainly":[71],"peripheral":[72],"edema":[73],"weight":[75,124],"gain)":[76],"may":[77],"conduct":[78],"treatment":[80],"cessation.":[81],"Several":[82],"pharmacological":[83,131],"classes":[84],"currently":[86],"pre-clinical":[88],"development,":[91],"the":[93,97,110,121,169],"objective":[94],"retain":[96],"beneficial":[98],"metabolic":[99],"properties":[100],"agonists,":[103,135,140,143],"either":[104],"alone":[105],"association":[108],"PPARalpha":[111],"(fibrates)":[113],"benefit":[114],"profile,":[117],"devoid":[119],"side-effects":[122],"gain":[125],"fluid":[127],"retention.":[128],"These":[129],"new":[130],"classes:":[132],"partial":[133],"antagonists,":[137],"dual":[138],"PPARalpha/PPARgamma":[139],"pan":[141],"PPARalpha/beta(delta)/gamma":[142],"RXR":[144],"receptor":[145],"(rexinoids),":[147],"presented":[149],"this":[151],"review.":[152],"Main":[153],"results":[154],"from":[155],"vitro":[157],"cell":[158],"experiments":[159],"model":[162],"studies":[163,173],"discussed,":[165],"as":[166,168],"few":[170],"published":[171],"short-term":[172],"patients.":[178]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}